Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Lawyers in Hair Relaxer Cancer Lawsuits Fail To Reach Agreement on Bellwether Plan Court has given the parties until January 3 to submit their competing plans for hair relaxer lawsuit bellwether trial protocols. December 19, 2024 Irvin Jackson Add Your Comments As the U.S. District Judge presiding over all federal hair relaxer lawsuits works to establish a bellwether trial program to help gauge evidence that will be repeated throughout thousands of claims brought by women diagnosed with uterine cancer, endometrial cancer and ovarian cancer, the parties reported last week that they have been unable to reach an agreement on the process for selecting the 16 cases that will be prepared to go before juries. There are currently nearly 10,000 product liability lawsuits pending in the federal court system against manufacturers of popular hair relaxer products, including Dark & Lovely, Just For Me, ORS Olive Oil and others, each raising similar allegations that users were not adequately warned about risks associated with endocrine disrupting chemicals contained in the hair straightening products. The litigation emerged after the publication of a study in October 2022, which highlighted a link between hair relaxers and cancer, finding that women who regularly used the products face a 156% increased risk of uterine cancer compared to women who did not use them. Other studies have also found that exposure to the chemical hair straighteners may cause ovarian cancer, as well as other injuries. Given common questions of fact and law presented in complaints brought by women throughout the U.S., the lawsuits have all been centralized in the Northern District of Illinois as part of a hair relaxer lawsuit MDL, or multidistrict litigation, where U.S. District Judge Mary Rowland is presiding over coordinated discovery and pretrial proceedings. HAIR RELAXER COMPENSATION Did you or a loved one use hair relaxer products? Uterine cancer, endometrial cancer and ovarian cancer may be caused by chemicals in hair relaxer. See if you are eligible for benefits. Learn More SEE IF YOU QUALIFY FOR COMPENSATION HAIR RELAXER COMPENSATION Did you or a loved one use hair relaxer products? Uterine cancer, endometrial cancer and ovarian cancer may be caused by chemicals in hair relaxer. See if you are eligible for benefits. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Early in the litigation, Judge Rowland indicated that the Court will establish a “bellwether” process, where a small group of representative claims will be prepared for early test trials, to help determine how juries may interpret certain evidence and testimony that will be repeated throughout a large number of claims. In November 2023, Judge Rowland ordered the parties to propose competing hair relaxer lawsuit bellwether trial plans, outlining a process for selecting a group of representative cases to go through case-specific discovery in preparation for early trial dates. However, the parties were unable to agree on several key points regarding the process for selecting representative claims, as well as when the bellwether trials should get underway. In advance of a status conference scheduled for January 9, the parties recently submitted a report (PDF) indicating that they have met and conferred several times, but remain unable to reach an agreement on several issues regarding the selection of 16 bellwether claims, or a briefing schedule. “[T]he bellwether selection process has effectively been in limbo since the parties’ prior briefing and the status conference regarding the same on January 25, 2024,” according to the plaintiffs’ position statement outlined in the report. “The 11-month delay has, in large part, been due to Defendants’ representations that they needed to receive and review a significant percentage of ‘substantially complete’ [Plaintiff Fact Sheets] before they could select their 8 bellwether pool cases (of the agreed to 16 cases).” In contrast, the manufacturers seek further delays in the bellwether process, indicating that plaintiffs are attempting to “force an immediate selection” of cases for trial, before discovery is complete and they have had a reasonable opportunity to review and process the totality of information that has been provided in each case. The defendants proposed that the court extend deadlines for considering the issue until after the “December-January holidays,” proposing that the parties submit simultaneous briefs no earlier than January 23, 2025. In a Docket Entry (PDF) entered on December 13, Judge Rowland rejected that proposed timeline, ordering the parties to submit briefings by January 3, 2025, not only regarding the selection process for the 16 bellwether cases, but also the timing for completing discovery in those claims. The Court indicates that it intends to issue a “comprehensive bellwether protocol,” which addresses additional issues beyond the process for selecting the individual hair relaxer cases that will go through case-specific discovery and preparations for early trial dates. While the outcome of the early bellwether trials held in the MDL will not have any binding impact on other claims being pursued, the average hair relaxer lawsuit payouts awarded by juries may have a substantial impact on settlement negotiations and the amount manufacturers may need to pay to avoid each individual claim going before a jury in future years. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Cancer, Endocrine Disruptors, Endometrial Cancer, Endometriosis, Hair Relaxer, Hair Straighteners, L'Oreal, Ovarian Cancer, Perm, Phthalates, Revlon, Uterine Cancer, Uterine Fibroids Find Out If You Qualify for Hair Relaxer Compensation More Hair Relaxer Lawsuit Stories Hair Relaxer Lawsuit MDL Status Hearings Scheduled Throughout 2026 November 13, 2025 Update on Hair Relaxer Lawsuit Status To Be Provided to Court at MDL Hearing November 5, 2025 Hair Relaxer Injury Lawsuit Against L’Oreal, Strength of Nature Cleared To Move Forward October 20, 2025 0 Comments LinkedInThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Sudden Ozempic Blindness Reports Raise Concerns Over NAION Side Effects (Posted: yesterday) An increasing number of Ozempic and Mounjaro users are reporting sudden, irreversible vision loss from NAION side effects, prompting new lawsuits and a federal push to consolidate blindness claims into a dedicated multidistrict litigation. MORE ABOUT: OZEMPIC LAWSUITOzempic, Similar Drugs Linked to Higher Risk of GI Side Effects: Study (11/21/2025)Lawsuits Over Ozempic Vision Loss and Gastrointestinal Injuries Will Be Separately Managed in NJ State Court (11/17/2025)Judge Extends Deadlines To Address GLP-1 Lawsuit ‘Cross-Cutting’ Issues (10/28/2025) Ongoing Cartiva Lawsuit Settlement Negotiations Cited as Reason to Reject MDL Consolidation (Posted: 2 days ago) Cartiva is urging federal judges to reject consolidation of toe-implant lawsuits, arguing that an MDL would interfere with individual claim resolutions that the company says are already being handled efficiently outside of court. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Lawsuits Allege Toe Implant Fails in About 64% of Patients (11/12/2025)MDL Sought for Cartiva Implant Lawsuits Filed in Federal Court System (11/03/2025)Lawsuit Claims Cartiva SCI Failure Caused by Defective Design of Big Toe Implant (09/18/2025) Covidien Symbotex Mesh Lawsuit Reset For Trial in July 2026 (Posted: 3 days ago) The first Covidien Symbotex mesh bellwether has been restored to the 2026 trial calendar, signaling renewed momentum in a litigation where more than 2,000 similar claims are still awaiting resolution. MORE ABOUT: HERNIA MESH LAWSUITFeb. 2026 Trial for Covidien Hernia Mesh Lawsuit Canceled by MDL Judge (11/05/2025)Covidien Seeks Dismissal of Lawsuits Over Hernia Mesh Complications (09/08/2025)Deadline for Covidien Mesh Settlement Negotiations Extended Until Jan. 2026 (08/21/2025)
Hair Relaxer Injury Lawsuit Against L’Oreal, Strength of Nature Cleared To Move Forward October 20, 2025
Sudden Ozempic Blindness Reports Raise Concerns Over NAION Side Effects (Posted: yesterday) An increasing number of Ozempic and Mounjaro users are reporting sudden, irreversible vision loss from NAION side effects, prompting new lawsuits and a federal push to consolidate blindness claims into a dedicated multidistrict litigation. MORE ABOUT: OZEMPIC LAWSUITOzempic, Similar Drugs Linked to Higher Risk of GI Side Effects: Study (11/21/2025)Lawsuits Over Ozempic Vision Loss and Gastrointestinal Injuries Will Be Separately Managed in NJ State Court (11/17/2025)Judge Extends Deadlines To Address GLP-1 Lawsuit ‘Cross-Cutting’ Issues (10/28/2025)
Ongoing Cartiva Lawsuit Settlement Negotiations Cited as Reason to Reject MDL Consolidation (Posted: 2 days ago) Cartiva is urging federal judges to reject consolidation of toe-implant lawsuits, arguing that an MDL would interfere with individual claim resolutions that the company says are already being handled efficiently outside of court. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Lawsuits Allege Toe Implant Fails in About 64% of Patients (11/12/2025)MDL Sought for Cartiva Implant Lawsuits Filed in Federal Court System (11/03/2025)Lawsuit Claims Cartiva SCI Failure Caused by Defective Design of Big Toe Implant (09/18/2025)
Covidien Symbotex Mesh Lawsuit Reset For Trial in July 2026 (Posted: 3 days ago) The first Covidien Symbotex mesh bellwether has been restored to the 2026 trial calendar, signaling renewed momentum in a litigation where more than 2,000 similar claims are still awaiting resolution. MORE ABOUT: HERNIA MESH LAWSUITFeb. 2026 Trial for Covidien Hernia Mesh Lawsuit Canceled by MDL Judge (11/05/2025)Covidien Seeks Dismissal of Lawsuits Over Hernia Mesh Complications (09/08/2025)Deadline for Covidien Mesh Settlement Negotiations Extended Until Jan. 2026 (08/21/2025)